adjuvant therapies in rcc: are new data practice changing?
Published 1 year ago • 53 plays • Length 3:30
Download video MP4
Download video MP3
Similar videos
-
0:35
the latest developments in adjuvant therapy for rcc
-
4:02
adjuvant rcc treatment considerations and final thoughts on rcc therapy
-
1:08:16
the uromigos: perioperative therapy in rcc
-
10:37
patient scenarios and treatment considerations in the adjuvant rcc setting
-
4:57
review of the data of frontline treatment for non-clear cell kidney cancer
-
6:17
in rcc, what is the optimal treatment for intermediate/poor-risk disease?
-
8:15
choosing an io/tki doublet for rcc patients: efficacy data, dosing, and more
-
1:03
potential of adjuvant therapy for rcc
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
0:35
defining and prognosticating nccrcc: constant molecular evolution #cancerresearch #news #cancer
-
17:40
rcc highlights from asco® gu: adjuvant treatment, immunotherapy, toxicities, and more
-
4:23
second-line treatment options for rcc
-
0:53
the role of icis in the adjuvant setting for rcc
-
0:43
what's on the horizon for adjuvant therapies for rcc?
-
2:35
adjuvant therapy in rcc: harnessing prognostic information
-
1:28:18
navigating evolving standards of care in rcc: novel targeted and immunotherapy options
-
28:07
management of locally advanced rcc (lnd, ivc, thrombus, adjuvant, neoadjuvant therapy)
-
55:53
adjuvant therapies in rcc: what we think we know
-
51:09
immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: asco gu 2023
Clip.africa.com - Privacy-policy